Heat-Not-Burn Could Replace Vapes to Help Adult Smokers Reduce Risk without Attracting Youth, Non-Smokers


Ryan Allway

October 12th, 2021

App, Exclusive, News, Top Story


Most adults and regulators recognize the harm of tobacco, but flavored high-nicotine vaping products have evaded regulatory scrutiny. While the U.K., Europe, and Canada outlawed vape products containing high nicotine levels, the FDA only recently denied marketing approval for hundreds of vape brands and ordered them off store shelves.

The new FDA ban prevents many more contemporary brands from reaching customers, but most established brands, like JUUL and blu, remain untouched—for now. These products represent more than two-thirds of the vape market and are still on store shelves, but the FDA could severely limit their nicotine content and only permit tobacco flavors in the near-term.

The original promise of the vaping industry was to help existing adult smokers transition to a less dangerous product and ultimately quit smoking. But, unfortunately, the FDA found in its review that vape companies provided no sound scientific evidence that their products help adult smokers quit—instead, they’re hooking high school and middle school students.

Youth Consumption on the Rise

More than three million U.S. high school students and another half-million middle school students use these vape products, addicted to high nicotine levels and flavors like menthol, fruit, candy, and mint. In 2020, about 83% of youth vape consumers chose flavored varieties, and vapes had nicotine levels two to three times greater than what Europe allows.

While the long-term health effects are unknown, a growing body of evidence suggests that vape products could adversely affect cardiovascular and lung health. For example, the aerosol produced by vaping cartridges may include cancer-causing chemicals, ultrafine particles, heavy metals, or volatile organic compounds (VOCs).

According to the CDC, high nicotine levels may also interfere with adolescent brain development, which continues into the early to mid-20s. Young people that vape may also be more likely to smoke cigarettes or consume in the future. And of course, the FDA found no evidence the vapes help existing smokers quit—the vape industry’s original promise.

Alternatives to Quit Smoking

Heat-not-burn (HNB) products could provide an alternative to help adult smokers quit or transition to a safer consumption method. Unlike vape products, HNB products are designed to feel like a traditional cigarette and mimic the smoking experience more accurately. In addition, there’s no flavoring to attract young students or non-smokers.

For example, the IQOS heats tobacco without burning it, producing the same experience with less smoke than a conventional cigarette. Another example is Poda Holdings, Inc. (CSE: PODA) (FSE: 99L) (OTC: PODAF), which takes a different approach by heating tea leaves and synthetic nicotine rather than tobacco to create an experience similar to a traditional cigarette without toxic chemicals.

See PODA CEO Ryan Selby discuss the company’s approach to smoking cessation

Click here to receive an investor presentation and corporate updates

The FDA authorized IQOS in July of 2020 to be marketed as a “modified risk” tobacco product, making it the first product to receive “exposure modification” orders. As a result, IQOS can advertise that switching from regular cigarettes to IQOS can reduce a person’s exposure to harmful chemicals, making it an actual smoking cessation solution.

Looking Ahead

The FDA is finally taking action against the vape industry. Meanwhile, the HNB industry could provide a more compelling alternative to help adult smokers reduce risk without attracting youth or non-smokers. The jury is still out on these products, but the FDA’s decisions regarding IQOS could pave the way for vapes to be replaced with HNB products.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading